Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HESTER PHARM Plunges 8%; BSE HEALTHCARE Index Up 0.5%
Thu, 19 Sep 9:20

HESTER PHARM Plunges 8%; BSE HEALTHCARE Index Up 0.5%Image source: peterschreiber.media/www.istockphoto.com

HESTER PHARM share price has plunged 8% and is presently trading at Rs 2,210.0.

Meanwhile, the BSE HEALTHCARE index is at 43,973.0 (up 0.5%).

Among the top losers in the BSE HEALTHCARE index today are AJANTA PHARMA (down 10.3%) and J.B.Chemicals (down 1.4%).

ASTER DM HEALTHCARE (up 3.8%) and ALEMBIC PHARMA (up 2.0%) are among the top gainers today.

Over the last one year, HESTER PHARM has moved up from Rs 1,698.1 to Rs 2,210.0, registering a gain of Rs 512.0 (up 30.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,508.7 to 43,973.0, registering a gain of 54.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 169.5%), SUVEN PHARMACEUTICALS (up 106.6%) and Lupin (up 95.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 83,359.2 (up 0.5%).

The top gainers among the BSE Sensex today are NTPC (up 2.8%) and HCl Tech. (up 1.7%). The most traded stocks in the BSE Sensex are NTPC and Tata Steel.

In the meantime, NSE Nifty is at 25,487.1 (up 0.4%). NTPC and LTIMINDTREE are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,596.8 to 83,359.2, registering a gain of 15,762.3 points (up 23.3%).

HESTER PHARM Financial Update...

HESTER PHARM net profit grew 24.1% YoY to Rs 66 million for the quarter ended June 2024, compared to a profit of Rs 53 million a year ago. Net sales declined 6.4% to Rs 823 million during the period as against Rs 879 million in April-June 2023.

For the year ended March 2024, HESTER PHARM reported 24.5% decrease in net profit to Rs 212 million compared to net profit of Rs 280 million during FY23. Revenue of the company grew 14.5% to Rs 3,045 million during FY24.

The current Price to earnings ratio of HESTER PHARM, based on rolling 12 month earnings, stands at 105.4.


Equitymaster requests your view! Post a comment on "HESTER PHARM Plunges 8%; BSE HEALTHCARE Index Up 0.5%". Click here!